13-16 November, 2014 Lisboa
5-P | Diagnostic accuracy of prostate histoscanning | Michael Mikhail | Received |
9-P | The Rotterdam prostate cancer risk calculator: Improved prediction with more relevant pre-biopsy information, now in the palm of your hand | Nuno Azevedo | Received |
10-P | PI-RADS and local staging (T) of Pca | Augusto Gaspar | Received |
12-P | Relationship between baseline IPSS and genitourinary toxicity from prostate stereotactic body radiotherapy (SBRT) | Ana Martos | Received |
16-P | Switching from conventional laparoscopic to robot-assisted laparoscopic prostatectomy in a single surgeon setting. Is it worth it? | Anneleen Verbrugghe | Received |
23-P | Correlation between planning scan rectal diameter and long term control in prostate cancer | John McGrane | Received |
26-P | Correlation between urinary continence and nerve sparing quality after radical retropubic prostatectomy | Vagif Atduev | Received |
30-P | Effect of neoadjuvant hormonal treatments on cancer specific survival of high-risk prostate cancer patients | Lorenzo Tosco | Received |
38-P | Volumetric surveillance of low risk prostate cancer with prostate histoscanning | Michael Mikhail | Received |
43-P | Matched pair study to assess the quality of life and toxicity in patients with carcinoma of the prostate undergoing external beam radiotherapy with or without a high dose rate brachytherapy boost | Anna Lydon | Received |
57-P | Prosper: A phase 3 study of enzalutamide in non-metastatic (M0) castration-resistant prostate cancer (CRPC) patients | Angela Mason | Received |
61-P | Cancer in urology Is there an App for that? A systematic review | Nuno Azevedo | Received |
64-P | To prospectively compare F18-Choline PET/CT and axial skeleton MRI for the detection of bone metastases in patients with biochemically recurrent prostate cancer (PCa) | Piet Ost | Received |
68-P | Bipolar plasma vaporization in prostate cancer related urinary retention A palliative modality of maintaining long term spontaneous voiding | Bogdan Geavlete | Received |
70-P | Oncological outcomes of radical prostatectomy for high-risk prostate cancer | Egor Sokolov | Received |
81-P | Efficacy of metronomic chemotherapy in metastatic castration resistant prostate cancer | Yumun Jeong | Received |
86-P | Disease characteristics influencing the duration of the off-treatment period during intermittent androgen deprivation therapy with degarelix in prostate cancer | Peter Bergqvist | Received |
88-P | Prostate cancer in area without screening | anna scavuzzo | Received |
92-P | 18F-FACBC compared with 11C-Choline PET/CT in patients with biochemical relapse after radical prostatectomy: A prospective study in 79 patients | Riccardo Schiavina | Received |
94-P | The impact of androgen deprivation therapy on bladder cancer recurrence: Retrospective analysis | Koji Izumi | Received |
99-P | The role of narrow band imaging and photodynamic diagnostic cystoscopies among patients with newly diagnosed bladder cancer | Ivan Pulin | Received |
105-P | A pathologically confirmed diagnostic accuracy parallel NBI versus standard cystoscopy in NMIBC daily practice | Bogdan Geavlete | Received |
110-P | Chronic obstructive pulmonary disease (COPD) as a complications predictor for radical cystectomy | Vagif Atduev | Received |
113-P | Design of an exploratory phase I study of pemetrexed in addition to vinflunine as second-line treatment in patients with metastatic urothelial cell carcinoma after prior treatment with platinum | Helle Pappot | Received |
117-P | Comparative study between surgery and radiochemotherapy in muscle invasive bladder TCC | Marc Wygoda | Received |
119-P | Intravesical bacile calmette-guerin in high-risk Non-Muscle Invasive Bladder Cancer (NMIBC): Adherence to European Association of Urology guidelines and outcomes during the BCG crisis | Zoe Gates | Received |
121-P | Prognostic factors and survival differences between primary and progressive muscle-invasive bladder cancer | Loreto Parra López | Received |
122-P | High visfatin expression predicts poor prognosis of upper tract urothelial carcinoma | Ing-Shiang Lo | Received |
126-P | Can we predict which patients with metastatic Renal Cell Carcinoma (mRCC) will develop Brain Metastases (BM)? | LISA DEROSA | Received |
127-P | NBI assisted flexible digital ureteroscopy A substantial improvement in upper urinary tract tumors detection | Bogdan Geavlete | Received |
129-P | Primary endoscopic intramural ureter approach using bipolar plasma vaporization during nephroureterectomy a novel alteration of the pluck technique | Bogdan Geavlete | Received |
132-P | Effectiveness of nephron-sparing surgery in tumors more than 7cm | Iurii Vitruk | Received |
133-P | Long term outcomes in the management of small renal masses &8804;4cm | Morkos Iskander | Received |
134-P | Treatment with antiangiogenics of advanced renal cancer: Are there differences between urologist and medical oncologist? | belen congregado | Received |
136-P | Complete remission of methastasic renal carcinoma in patients treated with tirosin kinase inhibitors. A multi institutional based study | Juan Braulio García Ramos | Received |
141-P | Simplified laparoscopic partial nephrectomy: Double layer technique | Sergey Dimitriadi | Received |
145-P | Long term outcomes in the management of renal cancers | Morkos Iskander | Received |
153-P | Does pelvic lymph node dissection have a role in the treatment of penile cancer? | Tet Yap | Received |
154-P | Factors predicting local recurrence of penile carcinoma (PC) An analysis of risk factors, patterns of recurrence and outcome | Tet Yap | Received |
156-EP | Using 11Ccholine PET/CT for staging and restaging prostate cancer | Giampiero Giovacchini | Received |
159-EP | Experience of cryoablation for small renal masses in our institute | Fumiya Hongo | Received |
161-EP | Diagnostic and clinical value of post PCNL nephrostogram | Asrit Babu | Received |
162-EP | MRI-guided salvage IMRT for prostate cancer | Piet Dirix | Received |
163-EP | MRI-guided high dose rate brachytherapy in the localized prostate cancer and the advantage to escalate the dose in the dominant intraprostatic lesion | FRANCISCO MASCARENHAS | Received |
164-A-EP | Post - nephrostomy sepsis and septic shock rate, predictive risk factors and ways of improving patient outcomes - an audit | Seth K.A Horsu | Received |
165-EP | Significant renal arteriovenous malformation in the context of a rare genetic disease: The Bannayan Riley Ruvalcaba Syndrome | Angel Daniel Urbina Lima | Received |
167-EP | A curiously large ureter: Imaging study of an incidental finding | Sana Ihsan | Received |
168-EP | Comparison of extracorporeal shock wave lithotripsy, ureterorenoscopy with YAG laser lithotripsy (URS), and percutaneous nethrolitholapaxy (PNL) methods for treatment of ureteral and kidney stones | Marat Kutluev | Received |
170-EP | Predicting radiation exposure in ureterorenoscopy and laser lithotripsy: An analysis of patient and stone characteristics | Vincent Lam | Received |
172-EP | Unopacified ureteral segments on CT Urography: Can we ignore them? | Christian Welch | Received |
13-16 November, 2014 Lisboa
Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress. |
||||
|